Insider · CIK 0001194020

DEC TIMOTHY C

Reports to the SEC for 4 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001194020

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	+1,250 sh	—	—	9,733
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	−1,250 sh	—	—	0
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−604 sh	$46.57	−$28.1K	9,129
2026-07-29	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Senior Vice-President & CFO	AAward	+1,250 sh	—	—	1,250
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,450 sh	$54.73	−$79.4K	8,232
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	+3,000 sh	—	—	8,115
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,433 sh	$54.73	−$78.4K	6,682
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	+3,000 sh	—	—	9,682
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	−3,000 sh	—	—	0
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	−3,000 sh	—	—	0
2026-02-28	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Senior Vice-President & CFO	AAward	+3,000 sh	—	—	3,000
2026-02-28	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Senior Vice-President & CFO	AAward	+3,000 sh	—	—	3,000
2026-02-25	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−2,500 sh	—	—	2,500
2026-02-25	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,279 sh	$50.69	−$64.8K	5,115
2026-02-25	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+2,500 sh	—	—	6,394
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−3,000 sh	—	—	6,000
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+1,125 sh	—	—	2,763
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+500 sh	—	—	2,660
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−1,125 sh	—	—	3,375
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−242 sh	$50.86	−$12.3K	2,418
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−603 sh	$51.35	−$31K	2,160
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+3,000 sh	—	—	5,418
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,524 sh	$50.86	−$77.5K	3,894
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−500 sh	—	—	0
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Senior Vice-President & CFO	AAward	+17.5K sh	—	—	17,500
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Senior Vice-President & CFO	AAward	+3,000 sh	—	—	3,000
2025-08-22	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Senior Vice-President & CFO	SSale	−11.8K sh	$44.49	−$524K	1,246
2025-03-10	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	−2,000 sh	—	—	0
2025-03-10	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−955 sh	$32.06	−$30.6K	12,681
2025-03-10	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	+1,800 sh	—	—	13,636
2025-03-10	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	+2,000 sh	—	—	12,898
2025-03-10	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,062 sh	$32.06	−$34K	11,836
2025-03-10	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Senior Vice-President & CFO	MExercise/Conversion	−1,800 sh	—	—	0
2025-03-05	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−276 sh	$33.05	−$9,121.8	13,815
2025-03-05	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,587 sh	$33.05	−$52.5K	12,228
2025-03-05	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,330 sh	$33.05	−$44K	10,898
2025-02-28	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Senior Vice-President & CFO	AAward	+2,000 sh	—	—	2,000
2025-02-28	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Senior Vice-President & CFO	AAward	+1,800 sh	—	—	1,800
2025-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−2,500 sh	—	—	5,000
2025-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+2,500 sh	—	—	14,091
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−3,000 sh	—	—	9,000
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−500 sh	—	—	500
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+3,000 sh	—	—	11,591
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+500 sh	—	—	8,591
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Senior Vice-President & CFO	AAward	+4,500 sh	—	—	4,500
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Senior Vice-President & CFO	AAward	+40K sh	—	—	40,000
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Senior Vice-President & CFO	AAward	+2,500 sh	—	—	8,504
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Senior Vice-President & CFO	FTax Payment	−1,314 sh	$29.06	−$38.2K	7,190
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Senior Vice-President & CFO	DDisposition to Issuer	−2,500 sh	—	—	7,500
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Senior Vice-President & CFO	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Aug 144
DEC TIMOTHY C0001194020-26-000015
SEC(opens sec.gov)
Jul 314
DEC TIMOTHY C0001194020-26-000013
SEC(opens sec.gov)
Mar 104
DEC TIMOTHY C0001194020-26-000010
SEC(opens sec.gov)
Mar 34
DEC TIMOTHY C0001194020-26-000008
SEC(opens sec.gov)
Feb 264
DEC TIMOTHY C0001194020-26-000006
SEC(opens sec.gov)
Feb 254
DEC TIMOTHY C0001194020-26-000004
SEC(opens sec.gov)

Companies

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850